Dr. Meg Mooney helps coordinate cancer clinical trial networks across the country and internationally, and also organizes initiatives related to innovative cancer treatment reviews and precision medicine. In this episode, Mooney discusses a new natural history study the National Cancer Institute launched for cancer patients with COVID-19, as well as the work being done in drug discovery and development during this time.
HealthCast
Season 1
Episode 10
18m listen
Dr. Meg Mooney, Associate Director of CTEP, NCI
The office coordinates nationwide testing of new treatment approaches for cancer.
-
Meg Mooney Associate Director of CTEP NCI
Related Content
-
Cyber Resilience and Recovery Amid Evolving Cyber Threats
Data durability is a key aspect of NIST’s cybersecurity framework for public and private organizations.
21m listen -
How Tech Enables Environmental Justice at EPA
The agency wants to eliminate bias and establish new tech standards to reduce greenhouse gas emissions.
39m listen -
Building Better Data Governance Across FDA
The agency is using emerging technology to tackle its data challenges.
19m listen -
Coast Guard Poised for Growth in Cyber
The service’s prevention policy chief discusses his priorities for combatting cyber incidents that could have global impacts.
23m listen